Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

PaperCitations, authors & open-access status

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 3,158 citations, 2018 year and bronze oa status.

3,158
Citations
2018
Year
bronze
OA Status

Related on ScholarIQ

Matthew D. Hellmann
Author
Julie R. Brahmer
Author
New England Journal of Medicine
Journal
Cancer Immunotherapy and Biomarkers
Topic
Cancer Immunotherapy and Biomarkers
Topic
Lung Cancer Diagnosis and Treatment
Topic
470M+ articles · free account